2026 Investor Day
Accelerating Diagnostics. Simplifying Complexity.
On May 20, 2026 Diasorin will present the new 2026-2030 Strategic Plan, outlining its vision for strategy and commercial execution in the coming years.
Agenda
12:30 - 14:00
- Participant registration and welcome
- Demonstration of immunodiagnostic and molecular diagnostic platforms
- Light lunch
14:00 – 17:00
- Investor Day – live presentation (also available via webcast)
In-person attendance
To confirm in-person attendance, please contact:
Live streaming
Register hereGet in touch
Riccardo Fava
Corporate Vice President Communication, ESG
& Investor Relations
Diasorin S.p.A.
riccardo.fava@diasorin.com
Eugenia Ragazzo
Corporate Investor Relations & ESG Senior Analyst
Diasorin S.p.A.
eugenia.ragazzo@diasorin.com